The Behavioral Effects of Opiates

  • David J. Mayer
Chapter

Abstract

This chapter will examine the effects of opiates on behavior, which immediately raises the questions of what are “opiates” and what constitutes “behavior.” Although both these terms can encompass widely varying domains, for the purpose of this chapter, they will not be very rigidly defined. Opiate will be used to denote chemicals with opium or morphine-like effects regardless of whether they are derived from plant or animal sources or whether they are synthetic. The term opioid will be used in a more restrictive sense, being reserved for substances endogenous to the mammalian central nervous system and synthetic analogs of them that have opiate like properties. Behavior will be used in a broad sense of the word, including any response of striated, smooth, or cardiac muscle, as well as secretion of glands. This approach will allow the examination of topics that are relatively simple and about which an instructive amount is known and may provide useful models for the examination of the role of opiates in more complex behaviors.

Keywords

Dorsal Horn Ventral Tegmental Area Endogenous Opioid Opiate Receptor Spinothalamic Tract 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ahren, B., and Lundquist, I., 1984, Effects of naloxone on basal and stimulated insulin secretion in the mouse, Eur. J. Pharmacol. 102: 135–139.PubMedGoogle Scholar
  2. Akil, H., Mayer, D., and Liebeskind, J., 1972, Comparaison chez le rat entre l’analgesie induite par stimulation de la substance grise periaqueducale et l’analgesia morphinique, C. R. Acad Sci. 274: 3603–3605.Google Scholar
  3. Akil, H., Madden, J., Patrick, R. L., and Barchas, J. D., 1976a, Stress-induced increase in endogenous opiate peptides: Concurrent analgesia and its partial reversal by naloxone, in: Opiates and Endogenous Opioid Peptides (H. W. Kosterlitz, ed.), Elsevier, North Holland, pp. 63–70.Google Scholar
  4. Akil, H., Mayer, D. J., and Liebeskind, J. C., 1976b, Antagonism of stimulation-produced analgesia by the narcotic antagonist, naloxone, Science 191: 961–962.PubMedGoogle Scholar
  5. Akil, H., Watson, S. J., Young, E., Lewis, M. E., Khachaturian, H., and Walker, J. M., 1984, Endogenous opioids: Biology and function, Annu. Rev. Neurosci. 7: 223–256.PubMedGoogle Scholar
  6. Albus, K., and Herz, A., 1972, Inhibition of behavioural and EEG activation induced by morphine acting on lower brain-stem structures, Electroencephalogr. Clin. Neurophysiol. 33: 579–590.Google Scholar
  7. Albus, K., Schott, M., and Herz, A., 1970, Interaction between morphine and morphine antagonists after systemic and intraventricular administration, Eur. J. Pharmacol. 12: 53–64.PubMedGoogle Scholar
  8. Appel, N. M., and Van Loon, G. R., 1983, Activation of angiotensin II receptors in brain potentiates the stimulating effect of endogenous opioid neurons on central sympathetic outflow, Peptides 4: 59–62.PubMedGoogle Scholar
  9. Arndt, J. O., Mikat, M., and Parasher, C., 1984, Fentanyl’s analgesic, respiratory, and cardiovascular actions in relation to dose and plasma concentration in unanesthetized dogs, Anesthesiology 61: 355–361.PubMedGoogle Scholar
  10. Arnsten, A. F. T., Segal, D. S., Neville, H. J., Hillyard, S. A., Janowski, D. S., Judd, L. L., and Bloom, F. E., 1983, Naloxone augments electrophysiological signs of selective attention in man, Nature 304: 725–726.PubMedGoogle Scholar
  11. Azami, J., Llewelyn, M. B., and Roberts, M. H. T., 1982, The contribution of nucleus reticularis paragigantocellularis and nucelus raphe magnus to the analgesia produced by systemically administered morphine, investigated with the microinjection technique, Pain 12:229–246.PubMedGoogle Scholar
  12. Baldwin, B. A., and Parrott, R. F., 1985, Effects of intracerebroventricular injection of naloxone on operant feeding and drinking in pigs, Pharmacol. Biochem. Behav. 22: 37–40.PubMedGoogle Scholar
  13. Barton, C., Basbaum, A. I., and Fields, H. L., 1980, Dissociation of supraspinal and spinal actions of morphine: A quantitative evaluation, Brain Res. 188: 487–498.PubMedGoogle Scholar
  14. Basbaum, A. I., Marley, N., and O’keefe, J., 1975, Effects of spinal cord lesions on the analgesic properties of electrical brain stimulation, in: Advances in Pain Research and Therapy: Proceedings of the First World Congress on Pain (J. J. Bonica and D. G. Albe-Fessard, eds.), Raven Press, New York, p. 268.Google Scholar
  15. Beitel, R. E., and Dubner, R., 1976, Sensitization and depression of C-polymodal nociceptors by noxious heat applied to the monkey’s face, in: Proceedings of the First World Congress on Pain (J. J. Bonica and D. Albefessard, eds.), Raven Press, New York, pp. 149–153.Google Scholar
  16. Belenky, G. L., Gelinas-Sorell, D., Kenner, J. R., and Holaday, J. W., 1983, Evidence for delta receptor involvement in the postictal antinociceptive responses to electroconvulsive shock in rats, Life Sci. 33: 585–586.Google Scholar
  17. Beleslin, D. B., Samardzic, R., Krstic, S. K., and Micic, D., 1982, Differences in central effects of β-endorphin and enkephalins: β-Endorphin a potent psychomotor stimulant, Neuropharmacology 21: 99–102.PubMedGoogle Scholar
  18. Belluzzi, J. D., and Stein, L., 1977, Enkephalin may mediate euphoria and drive-reduction reward, Nature 266: 556–557.PubMedGoogle Scholar
  19. Benton, D., 1984, The long-term effects of naloxone, dibutyryl cyclic CMP, and chlorpromazine on aggression in mice monitored by an automated device, Aggress. Behav. 10: 79–90.Google Scholar
  20. Berman, R. F., Lee, J. A., Olson, K. L., and Goldman, M. S., 1984, Effects of naloxone on ethanol dependence in rats, Drug Alcohol Dependence 13: 245–254.Google Scholar
  21. Bernatsky, G., Doi, T., and Jurna, I., 1983, Effects of intrathecally administered pentobarbital and naloxone on the activity evoked in ascending axons of the rat spinal cord by stimulation of afferent A and C fibres. Further evidence for a tonic endorphinergic inhibition in nociception, Arch. Pharmacol. 323: 211–216.Google Scholar
  22. Bertiere, M. C., Sy, T. M., Baigts, F., Mandenoff, A., and Apfelbaum, M., 1984, Stress and sucrose hyperphagia: Role of endogenous opiates, Pharmacol. Biochem. Behav. 20: 675–680.PubMedGoogle Scholar
  23. Bhargava, H. N., 1983, Binding of (3H)spiroperidol to striatal membranes of rats treated chronically with morphine. Influence of pro-leu-gly-NH2 and cyclo(leu-gly), Neuropharmacology 22: 1357–1362.PubMedGoogle Scholar
  24. Bielajew, C., and Shizgal, P., 1982, Behaviorally derived measures of conduction velocity in the substrate for rewarding medial forebrain bundle stimulation, Brain Res. 237: 107–119.PubMedGoogle Scholar
  25. Blair, R., Cytryniak, H., Shizgal, P., and Amit, Z., 1980, Heroin, but not levorphanol produces explosive motor behavior in naloxone-treated rats, Psychopharmacology 69: 313–314.PubMedGoogle Scholar
  26. Bloom, F., Segal, D., Ling, N., and Guillemin, R., 1976, Endorphins: Profound behavioral effects in rats suggest new etiological factors in mental illness, Science 194: 630–632.PubMedGoogle Scholar
  27. Blum, I., Munitz, H., Shalev, A., and Roberts, E., 1984, Naloxone may be beneficial in the treatment of tardive dyskinesia, Clin. Neuropharmacol. 7: 265–267.PubMedGoogle Scholar
  28. Boada, J., Feria, M., and Sanz, E., 1981, Inhibitory effect of naloxone on the ethanol- induced antinociception in mice, Pharmacol. Res. Commun. 13: 673–679.PubMedGoogle Scholar
  29. Bodnar, R. J., Sharpless, N. S., Kordower, J. H., Potegal, M. and Barr, G. A., 1982, Analgesic responses following adrenal demedullation and peripheral catecholamine depletion, Physiol. Behav. 29: 1105–1109.PubMedGoogle Scholar
  30. Bodnar, R. J., Nilaver, G., Wallace, M. M., Badillo-Martinez, D., and Zimmerman, E. A., 1984, Pain threshold changes in rats following central injection of beta-endorphin, met-enkephalin, vasopressin or oxytocin antisera, Int. J. Neurosci. 24: 149–160.PubMedGoogle Scholar
  31. Bonica, J. J., 1980, Pain research and therapy: past and current status and future needs, in: Pain Discomfort and Humanitarian Care (L. K. Y. Ng and J. J. Bonica, eds.), Elsevier, New York, pp. 1–46.Google Scholar
  32. Bouras, C., Taban, C. H., and Constantinidis, J., 1984, Mapping of enkephalins in human brain. An immunohistofluorescence study on brains from patients with senile and presenile dementia, Neuroscience 12: 179–190.PubMedGoogle Scholar
  33. Bowker, R. M., Westlund, K. N., Sullivan, M. C., Wilber, J. F., and Coulter, J. D., 1983, Descending serotonergic, peptidergic and cholinergic pathways from the raphe nuclei: A multiple transmitter complex, Brain Res. 288: 33–48.PubMedGoogle Scholar
  34. Bozarth, M. A., 1982, Opiate reward mechanisms mapped by intracranial self-administration, in: Neurobiology of Opiate Reward Mechanisms (J. E. Smith and J. D. Lane, eds.), Raven Press, New York.Google Scholar
  35. Bozarth, M. A., and Wise, R. A., 1981a, Intracranial self-administration of morphine into the ventral tegmental area in rats, Life Sci. 28: 551–555.PubMedGoogle Scholar
  36. Bozarth, M. A., and Wise, R. A., 1981b, Heroin reward is dependent on a dopamingergic substrate, Life Sci. 29:1881–1886.Google Scholar
  37. Bozarth, M., and Wise, R. A., 1984, Anatomically distant opiate receptor fields mediate reward and physical dependence, Science 224: 516–518.PubMedGoogle Scholar
  38. Brain, P. F., Jones, S. E., Brain, S., and Benton, D., 1984, Sequence analysis of social behavior illustrating the actions of 2 antagonists of endogenous opioids, in: Ethopharmacological Aggression Behavior (K. A. Miczek, M. R. Kruk, and B. Olivier, eds.), Liss, New York, pp. 43–58.Google Scholar
  39. Brambilla, F., Facchinetti, F., Petraglia, F., Vanzulli, L., and Genazzani, A. R., 1984, Secretion pattern of endogenous opioids in chronic schizophrenia, Am. J. Psychiatry 141: 1183–1188.PubMedGoogle Scholar
  40. Britt, M. D., and Wise, R. A., 1983, Ventral tegmental site of opiate reward: Antagonism by a hydrophilic opiate receptor blocker, Brain Res. 258: 105–108.Google Scholar
  41. Britton, K. T., Stewart, R. D., and Risch, S. C., 1983, Benzodiazepines attenuate stimulated beta-endorphin release, Psychopharmacol. Bull. 19: 757–759.Google Scholar
  42. Bunney, W. C., Massari, V. J., and Pert, A., 1984, Chronic morphine-induced hyperactivity in rats is altered by nucleus accumbens and ventral tegmental lesions, Psychopharmacology 82: 318–321.PubMedGoogle Scholar
  43. Burks, T. F., and Grubb, M. N., 1974, Sites of acute morphine tolerance in intestine, J. Pharmacol. Exp. Ther. 191: 518–526.PubMedGoogle Scholar
  44. Burleigh, D. E., Galligan, J. J., and Burks, T. F., 1981, Subcutaneous morphine reduces intestinal propulsion in rats partly by a central action, Eur. J. Pharmacol. 75: 283–287.PubMedGoogle Scholar
  45. Butler, P. D., and Bodnar, R. J., 1984, Potentiation of foot shock analgesia by thyrotropin releasing hormone, Peptides 5: 635–640.PubMedGoogle Scholar
  46. Carter, D. A., and Lightman, S. L., 1984, Inhibition of vasopressin secretion by a kappa- opiate receptor agonist, Neuroendocrinol. Lett. 6: 95–100.Google Scholar
  47. Cervero, F., Schouenborg, J., and Sjolund, B. H., 1981, Effects of conditioning stimulation of somatic and visceral afferent fibres on viscero-somatic reflexes, J. Physiol. 317: 27–28.Google Scholar
  48. Chang, K-J., 1984, Opioid peptides have actions on the immune system, Trends Neurosci. 7: 234–235.Google Scholar
  49. Charness, M. E., Gordon, A. S., and Diamond, I., 1983, Ethanol modulation of opiate receptors in cultured neural cells, Science 222: 1246–1248.PubMedGoogle Scholar
  50. Chung, J. M., Fang, Z. R., Cargill, C. L., and Willis, W. D., 1983, Prolonged, naloxone- reversible inhibition of the flexion reflex in the cat, Pain 15: 35–54.Google Scholar
  51. Clarke, G., and Patrick, G., 1983, Differential inhibitory action by morphine on the release of oxytocin and vasopressin from the isolated neural lobe, Neurosci. Lett. 39: 175–180.PubMedGoogle Scholar
  52. Cohen, M. R., Cohen, R. M., Pickar, D., Weingartner, H., and Murphy, D. L., 1983, High-dose naloxone infusions in normals, Arch. Gen. Psychiatry 40: 613–619.PubMedGoogle Scholar
  53. Cohen, M. R., Cohen, R. M., Pickar, D., Sunderland, T., Mueller, E. A., III, and Murphy, D. L., 1984, High dose naloxone in depression, Biol. Psychiatry 19: 825–832.PubMedGoogle Scholar
  54. Cohen, M. R., Cohen, R. M., Pickar, D., and Murphy, D. L., 1985, Naloxone reduces food intake in humans, Psychosom. Med. 47: 132–138.PubMedGoogle Scholar
  55. Cooper, S. J., 1983, Benzodiazepine-opiate antagonist interactions in relation to anxiety and appetite, Trends Pharmacol. Sci. 4: 456–458.Google Scholar
  56. Cooper, S. J., and Sanger, D. J., 1984, Endorphinergic mechanisms in food, salt and water intake—an overview, Appetite 5: 1–6.PubMedGoogle Scholar
  57. Corbett, D., and Wise, R. A., 1980, Intracranial self-stimulation in relation to the ascending dopaminergic systems of the midbrain: A moveable electrode mapping study, Brain Res. 185: 1–15.PubMedGoogle Scholar
  58. Costa, E., Guidotti, A., Hanbauer, I., and Saiani, L., 1983, Modulation of nicotinic receptor function by opiate recognition sites highly selective for met5-enkephalin- [arg6phe7]l, Fed. Proc. 42: 2946–2952.PubMedGoogle Scholar
  59. Costall, B., and Naylor, R. J., 1974, A role for the amygdala in the development of the cataleptic and stereotypic actions of the narcotic agonists and antagonists in the rat, Psychopharmacology 35: 203–214.Google Scholar
  60. Cowan, A., and Gmerek, D. E., 1982, In vivo studies with ICI 154, 129, a putative delta receptor antagonist, Life Sci. 31: 2213–2216.PubMedGoogle Scholar
  61. Czech, D. A., Blake, M. J., and Stein, E. A., 1984, Drinking behavior is modulated by CNS administration of opioids in the rat, Appetite 5: 15–24.PubMedGoogle Scholar
  62. Davis, G. C., Bunney, W., E. Jr., Defraites, E. G., Kleinman, J. E., Van Kammen, D. P., Post, R. M., and Wyatt, R. J., 1977, Intravenous naloxone administration in schizophrenia and affective illness, Science 197: 74–77.PubMedGoogle Scholar
  63. de Caro, G., Micossi, L. G., and Venturi, F., 1979, Drinking behaviour induced by intra-cerebroventricular administration of enkephalins to rats, Nature277: 51–52.PubMedGoogle Scholar
  64. Dehen, H., Willer, J. C., Prier, S., Boureau, F., and Cambier, J., 1978, Congenital insensitivity to pain and the “morphinelike” analgesic system, Pain 5: 351–358.PubMedGoogle Scholar
  65. Deviche, P., and Schepers, G., 1984, Intracerebroventricular injection of ostrich beta- endorphin to satiated pigeons induces hyperphagia but not hyperdipsia, Peptides 5: 691–694.PubMedGoogle Scholar
  66. Deviche, P., and Wohland, A., 1984, Opiate antagonists stereoselectively attenuate the consumption of food but not of water by pigeons, Pharmacol. Biochem. Behav. 21: 507–512.PubMedGoogle Scholar
  67. Devoize, J-L., Rigal, F., Eschalier, A., Trolese, J-F. and Renoux, M., 1984, Influence of naloxone on antidepressant drug effects in the force swimming test in mice, Psychopharmacology 84: 71–75.PubMedGoogle Scholar
  68. Dewey, W. L., Snyder, J. W., Harris, L. S., and Howes, J. F., 1969, The effect of narcotics and narcotic antagonists on the tail-flick response in spinal mice, J. Pharm. Pharmacol. 21: 548–550.PubMedGoogle Scholar
  69. Dewitte, P., 1984, Naloxone reduces alcohol intake in a free-choice procedure even when both drinking bottles contain saccharin sodium or quinine substances, Neuropsychobiology 12: 73–77.Google Scholar
  70. Dick, P., Grandjean, M. E., and Tissot, R., 1983, Successful treatment of withdrawal symptoms with delta sleep-inducing peptide, a neuropeptide with potential agonistic activity on opiate receptors, Neuropsychobiology 10: 205–208.PubMedGoogle Scholar
  71. Doi, T., and Jurna, I., 1982, Intrathecal pentobarbital prevents naloxone-induced facilitation of the tail-flick response in the rat, Neurosci Lett. 32: 81–84.PubMedGoogle Scholar
  72. Domjan, M., and Siegel, S., 1983, Attenuation of the aversive and analgesic effects of morphine by repeated adminsitration: Different mechanisms, Physiol. Psychol. 11: 155–158.Google Scholar
  73. Dostrovsky, J. O., and Deakin, J. F. W., 1977, Periaqueductal grey lesions reduce morphine analgesia in the rat, Neurosci. Lett 4: 99–103.PubMedGoogle Scholar
  74. Duggan, A. W., and North, R. A., 1983, Electrophysiology of opioids. 3, Pharmacol. Rev. 35: 219–282.PubMedGoogle Scholar
  75. Dum, J., and Herz, A., 1984, Endorphinergic modulation of neural reward systems indicated by behavioral changes, Pharmacol. Biochem. Behav. 21: 259–266.PubMedGoogle Scholar
  76. Dumont, M., and Lemaire, S., 1984, Opioid receptors in bovine adrenal medulla, Can. J. Physiol. Pharmacol. 62: 1284–1291.PubMedGoogle Scholar
  77. Emrich, H. M., Guenther, R., and Dose, M., 1983, Current perspectives in the pharmacopsychiatry of depression and mania, Neuropharmacology 22: 385–388.PubMedGoogle Scholar
  78. Eshel, Y., and Korczyn, A. M., 1985, Circling behavior induced by phencyclidine in mice and its inhibition by naloxone, Experientia 41: 73–74.PubMedGoogle Scholar
  79. Evans, C. J., Erdelyi, E., Weber, E., and Barchas, J. D., 1983, Identification of pro-opiomelanocortin-derived peptides in the human adrenal medulla, Science 221: 957–960.PubMedGoogle Scholar
  80. Facchinetti, F., Sandrini, G., Petraglia, F., Alfonsi, E., Nappi, G., and Genazzani, A. R., 1984, Concomitant increase in nociceptive flexion reflex threshold and plasma opioids following transcutaneous nerve stimulation, Pain 19: 295–304.PubMedGoogle Scholar
  81. Faden, A. I., and Feuerstein, G., 1983, Hypothalamic regulation of the cardiovascular and respiratory systems: Role of specific opiate receptors, Br. J. Pharmacol. 79: 997–1002.PubMedGoogle Scholar
  82. Faden, A. I., and Jacobs, T. P., 1983, Dynorphin induces partially reversible paraplegia in the rat, Eur. J. Pharmacol. 91: 321–324.PubMedGoogle Scholar
  83. Faden, A. I., Jacobs, T. P., Smith, G. P., Green, B., and Zivin, J. A., 1983, Neuropeptides in spinal cord injury: Comparative experimental models, Peptides 4: 631–634.PubMedGoogle Scholar
  84. Fanselow, M. S., Sigmundi, R. A., and Bolles, R. C., 1980, Naloxone pretreatment enhances shock-elicited aggression, Physiol. Psychol. 8: 369–371.Google Scholar
  85. Faris, P., Komisurak, B., Watkins, L., and Mayer, D. J., 1983, Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia, Science 219: 310–312.PubMedGoogle Scholar
  86. Fekete, M., Drago, F., Van Ree, J. M., Bohus, B., Wiegant, V. M., and De Wied, D., 1983, Naltrexone-sensitive behavioral actions of the ACTH 4-9 analog (ORG 2766), Life Sci. 32: 2193–2204.PubMedGoogle Scholar
  87. Fekete, M. I. K., Kanyicska, B., Szentendrei, T., and Stark, E., 1984, Loss of sensitivity to morphine induced by prolonged ACTH treatment, Pharmacol. Biochem. Behav. 20: 879–882.PubMedGoogle Scholar
  88. Feldberg, W., and Wei, E., 1978a, Central sites at which morphine acts when producing cardiovascular effects, J. Physiol. 275: 57.Google Scholar
  89. Feldberg, W., and Wei, E., 1978b, Central cardiovascular effects of enkephalins and C- fragment oflipotropin, J. Physiol. 280:18.Google Scholar
  90. Feurstein, G., and Faden, A. I., 1982, Hypothalamic sites for cardiovascular regulation by mu, delta, or kappa opioid agonists, Life Sci. 31: 2197–2200.Google Scholar
  91. Florez, J., and Mediavilla, A., 1977, Respiratory and cardiovascular effects of met- enkephalin applied to the ventral surface of the brain stem, Brain Res. 138: 585–590.PubMedGoogle Scholar
  92. Frenk, H., 1983, Pro- and anticonvulsant actions of morphine and the endogenous opioids: Involvement and interactions of multiple opiate and non-opiate systems, Brain Res. Rev. 6: 197–210.Google Scholar
  93. Frenk, H., and Stein, B. E., 1984, Endogenous opioids mediate ECS-induced catalepsy at supraspinal levels, Brain Res. 303: 109–112.PubMedGoogle Scholar
  94. Frenk, H., Urca, G., and Liebeskind, J. C., 1978, Epileptic properties of leucine- and methionine-enkephalin: Comparison with morphine and reversibility by naloxone, Brain Res. 147: 327–337.PubMedGoogle Scholar
  95. Frenk, H., Liban, A., Balamuth, R., and Urca, G., 1982, Opiate and non-opiate aspects of morphine induced seizures, Brain Res. 253: 253–261.PubMedGoogle Scholar
  96. Frenk, H., Watkins, L. R., and Mayer, D. J., 1984a, Differential behavioral effects induced by intrathecal microinjection of opiates: Comparison of convulsive and cataleptic effects produced by morphine, methadone, and D-Ala2-methionine-enkephalinamide, Brain Res. 299: 31–42.Google Scholar
  97. Frenk, H., Watkins, L. R., Miller, J., and Mayer, D. J., 1984b, Nonspecific convulsions are induced by morphine but not D-Ala2-methionine-enkephalinamide at cortical sites, Brain Res. 299: 51–59.Google Scholar
  98. Gallagher, M., 1982, Naloxone enhancement of memory processes: Effects of other opiate antagonists, Behav. Neural. Biol. 35: 375–382.PubMedGoogle Scholar
  99. Gallagher, M., King, R. A., and Young, N. B., 1983, Opiate antagonists improve spatial memory, Science 221: 975–976.PubMedGoogle Scholar
  100. Galligan, J. J., and Burks, T. F., 1982, Opioid peptides inhibit intestinal transit in the rat by a central mechanism, Eur. J. Pharmacol. 85: 61–68.PubMedGoogle Scholar
  101. Galligan, J. J., Mosberg, H. I., Hurst, R., Hruby, V. J., and Burks, T. F., 1984, Cerebral delta-opioid receptors mediate analgesia but not the intestinal motility effects of intra- cerebroventricularly administered opioids, J. Pharmacol. Exp. Ther. 229: 641–648.PubMedGoogle Scholar
  102. Geller, E. B., Hawk, C., Keinath, S. H., Tallarida, R. J., and Adler, M. W., 1983, Subclasses of opioids based on body temperature change in rats—acute subcutaneous administration, J. Pharmacol. Exp. Ther. 225: 391–398.PubMedGoogle Scholar
  103. Gerber, G. J., Sing, J., and Wise, R. A., 1981, Pimozide attenuates lever pressing for water reinforcement in rats, Pharmacol. Biochem. Behav. 14: 201–205.PubMedGoogle Scholar
  104. Gessa, G. L., Paglietti, E., and Quarantotti, B. P., 1979, Induction of copulatory behavior in sexually inactive rats by naloxone, Science 204: 203–205.PubMedGoogle Scholar
  105. Gillman, M. A., and Sandyk, R., 1985, Reversal of captopril-induced psychosis with naloxone, Am. J. Psychiatry 142: 270.PubMedGoogle Scholar
  106. Giraud, A. S., Dockray, G. J., and Williams, R. G., 1984, Immunoreactivity met-enkephalin arg6 in rat brain, and bovine brain, gut and adrenal, J. Neurochem. 43: 1236–1242.PubMedGoogle Scholar
  107. Gonzalez, Y., Fernandez-Tome, M. P., Sanchez-Franco, F., and Del Rio, J., 1984, Antagonism of diazepam-induced feeding in rats by antisera to opioid peptides, Life Sci. 35: 1423–1430.PubMedGoogle Scholar
  108. Gosnell, B. A., Waggoner, D. W., Morley, J. E., and Levine, A. S., 1985, The pineal gland and opiate-induced feeding, Physiol. Behav. 34: 1–6.PubMedGoogle Scholar
  109. Griffiths, E. C., Slater, P., and Widdowson, P. S., 1983, Effects of opioids, neurotensin and thyrotrophin releasing hormone on rectal temperature after application to periaqueductal grey region of rat brain, J. Physiol. (London) 342: 38 P.Google Scholar
  110. Haddad, G. G., Schaeffer, J. I., and Chang, K. J., 1984, Opposite effect of the δ- and μ-opioid receptor agonists on ventilation in conscious adult dogs, Brain Res. 323: 73–82.PubMedGoogle Scholar
  111. Hahn, E. F., 1984, Interaction of naloxone and sodium chloride intake on body weight gain in WKY and SHR rats, Res. Commun. Chem. Pathol. Pharm. 44: 339–346.Google Scholar
  112. Haigler, H. J., and Spring, D. D., 1978, Comparison of analgesic and behavioral effects of [D-Ala2] met-enkephalinamide and morphine in mesencephalic reticular formation of rats, Life Sci. 23: 1229–1240.PubMedGoogle Scholar
  113. Hammond, D. L., and Proudfit, H. K, 1980, Effects of locus coeruleus lesions on morphine-induced antinociception, Brain Res. 188: 79–91.PubMedGoogle Scholar
  114. Hardy, J. D., Wolff, H. G., and Goodell, H., 1952, Pain Sensations and Reactions, Williams & Wilkins, Baltimore.Google Scholar
  115. Hayes, R. L., Bennett, G. J., Newlon, P., and Mayer, D. J., 1976, Analgesic effects of certain noxious and stressful manipulations in the rat, Soc. Neurosci Abstr. 2: 939.Google Scholar
  116. Hayes, R. L., Bennett, G. J., Newlon, P. G., and Mayer, D. J., 1978a, Behavioral and physiological studies on non-narcotic analgesia in the rat elicited by certain environmental stimuli, Brain Res. 155: 69–90.Google Scholar
  117. Hayes, R. L., Price, D. D., Bennett, G. J., Wilcox, G. L., and Mayer, D. J., 1978b, Differential effects of spinal cord lesions on narcotic and non-narcotic suppression of nociceptive reflexes: Further evidence for the physiologic multiplicity of pain modulation, Brain Res. 155: 91–101.PubMedGoogle Scholar
  118. Hayes, R. L., Katayama, Y., Watkins, L. R., and Becker, D. P., 1984, Bilateral lesions of the dorsolateral funiculus of the cat spinal cord: Effects on basal nociceptive reflexes and nociceptive suppression produced by cholinergic activation of the pontine para- brachial region, Brain Res. 311: 267–280.PubMedGoogle Scholar
  119. Herling, S., 1983, Naltrexone blocks the response-latency increasing effects but not the discriminative effects of diazepam in rats, Eur. J. Pharmacol. 88: 121–124.PubMedGoogle Scholar
  120. Hiller, J. M., Pearson, J., and Simon, E. J., 1973, Distribution of stereospecific binding of the potent narcotic analgesic etorphine in the human brain: Predominance in the limbic system, Res. Commun. Chem. Pathol. Pharm. 6: 1052–1062.Google Scholar
  121. Holaday, J. W., 1983, Cardiovascular effects of endogenous opiate systems, Annu. Rev. Pharmacol. Toxicol. 23: 541–594.PubMedGoogle Scholar
  122. Holaday, J. W., 1984, Neuropeptides in shock and traumatic injury—sites and mechanisms of action, in: Neuroendocrine Perspectives (E. E. Muller and R. M. MacLeod, eds.), Elsevier Scientific Publishing, New York, pp. 161–200.Google Scholar
  123. Holaday, J. W., and Faden, A. I., 1978, Naloxone reversal of endotoxin hypotension suggests role of endorphins in shock, Nature 275: 450–451.PubMedGoogle Scholar
  124. Holaday, J. W., and Faden, A. I., 1982, Selective cardiorespiratory differences between third and fourth ventricular injections on “mu” and “delta” opiate agonists, Fed. Proc. 41: 1468.Google Scholar
  125. Holaday, J. W., and Loh, H. H., 1981, Neurobiology of beta-endorphin and related peptides, in: Hormonal Proteins and Peptides (C. H. Li, ed.), Academic Press, New York, pp. 202–290.Google Scholar
  126. Holaday, J. W., and Tortella, F. C., 1984, Multiple opioid receptors: Possible physiological functions of mu and delta binding sites in vivo, in: Central and Peripheral Endorphins: Basic and Clinical Aspects (E. E. Mueller and A. R. Genazzani, eds.), Raven Press, New York, pp. 237–250.Google Scholar
  127. Holaday, J. W., and Ward, S. J., 1982, Morphine-induced bradycardia is predominantly mediated at mu sites, whereas morphine-induced hypotension may involve both mu and delta opioid receptors, Soc. Neurosci. Abst. 8: 389.Google Scholar
  128. Holaday, J. W., Loh, H. H., and Li, C. H., 1978, Unique behavioral effects of beta-endorphin and their relationship to thermoregulation and hypothalamic function, Life Sci. 22: 1525–1536.PubMedGoogle Scholar
  129. Holaday, J. W., D’Amato, R. J., Ruvio, B. A., and Faden, A. I., 1982a, Action of naloxone and TRH on the autonomic regulation of circulation, in: Advances in Biochemical Psychopharmacology (E. Costa and M. Trabucchi, eds.), Raven Press, New York, pp. 353–362.Google Scholar
  130. Holaday, J. W., Ruvio, B. A., and Sickel, J., 1982b, Morphine exacerbates the cardiovascular pathophysiology of endotoxic shock in rats, Circ. Shock 9: 169.Google Scholar
  131. Holaday, J. W., Gilbeau, P. W., Smith, C. G., and Pennington, L. L., 1984, Multiple opioid receptors in the regulation of neuroendocrine responses in the conscious rat and monkey, in: Opioid Modulation of Endocrine Function (G. Delitala, M. Motta, and M. Serio, eds.), Raven Press, New York, pp. 21–32.Google Scholar
  132. Holden, D., 1985, ADAMHA funding pressed, Science 227: 147–149.PubMedGoogle Scholar
  133. Holmes, L. J., and Wise, R. A., 1985, Contralateral circling induced by tegmental morphine: Anatomical localization, pharmacological specificity, and phenomenology, Brain Res. 326: 19–26.PubMedGoogle Scholar
  134. Hughes, G. S., Jr., 1984, Naloxone and methylprednisolone sodium succinate enhance sympathomedullary discharge in patients with septic shock, Life Sci. 35: 2319–2326.PubMedGoogle Scholar
  135. Hughes, J., 1975, Search for the endogenous ligand of the opiate receptor, Neurosci. Res. Program Bull. 13: 55–58.Google Scholar
  136. Irwin, S., Houde, R. W., Bennett, D. R., Hendershot, L. C., and Seevers, M. H., 1951, The effects of morphine, methadone and meperidine on some reflex responses of spinal animals to nociceptive stimulation, J. Pharmacol. Exp. Ther. 101: 132–143.PubMedGoogle Scholar
  137. Ito, K., Nakamura, H., Sato, A., and Sato, Y., 1983, Depressive effect of morphine on the sympathetic reflex elicited by stimulation of unmyelinated hindlimb afferent nerve fibers in anesthetized cats, Neurosci Lett. 39: 169–174.PubMedGoogle Scholar
  138. Iversen, L. L., Iversen, S. D., Bloom, F. E. Vargo, T., and Guillemin, R., 1978, Release of enkephalin from rat globus pallidus in vitro, Nature 271: 679–680.PubMedGoogle Scholar
  139. Iwata, N., and Sakai, Y., 1971, Effects of some narcotic analgesics and related compounds upon the extensor monosynaptic reflex inhibition from cutaneous nerve and high threshold muscle afferent, Jpn. J. Pharmacol 21: 447–454.PubMedGoogle Scholar
  140. Jackson, H. C., and Sewell, R. D. E., 1984, The involvement of mu- and kappa- but not delta-opioid receptors in the body weight gain of suckling rats, Psychopharmacology 84: 143–144.PubMedGoogle Scholar
  141. Jackson, H. D., and Sewell, R. D. E., 1985, Involvement of endogenous enkephalins in the feeding response to diazepam, Eur. J. Pharmacol 107: 389–392.PubMedGoogle Scholar
  142. Jacquet, Y. F., 1978, Opiate effects after adrenocorticotropin or beta-endorphin injection in the periaqueductal gray matter of rats, Science 201: 1032–1034.PubMedGoogle Scholar
  143. Jacquet, Y. F., 1982, Dual actions of morphine on the central nervous system: parallel action of beta-endorphin and ACTH, Ann. NY Acad. Sci. 398: 272–290.PubMedGoogle Scholar
  144. Jacquet, Y. F., and Lajtha, A., 1973, Morphine action at central nervous system sites in rat: Analgesia or hyperalgesia depending on site and dose, Science 182: 490–491.PubMedGoogle Scholar
  145. Jacquet, Y. F., and Lajtha, A., 1974, Paradoxical effects after microinjection of morphine in the periaqueductal gray matter in the rat, Science 185: 1055–1057.PubMedGoogle Scholar
  146. Jacquet, Y. F., and Wolf, G., 1981, Morphine and ACTH1-24: Correlative behavior excitation following microinjection in rat periaqueductal gray, Brain Res. 219: 214–219.PubMedGoogle Scholar
  147. Jacquet, Y. F., Carol, M. and Russell, I. S., 1976, Morphine-induced rotation in naive, nonlesioned rats, Science 192: 261.PubMedGoogle Scholar
  148. Jaffe, J. H., and Martin, W. R., 1980, Opioid analgesics and antagonsits, in: The Pharmacological Basis of Therapeutics (A. G. Gilman, L. S. Goodman, and A. Gilman, eds.), Macmillan, New York, pp. 494–534.Google Scholar
  149. Janal, M. N., Colt, E. W. D., Clark, W. C., and Glusman, M., 1984, Pain sensitivity, mood and plasma endocrine levels in man following long-distance running: Effects of naloxone, Pain 19: 13–26.PubMedGoogle Scholar
  150. Janssen, H. F., and Lutherer, L. O., 1980, Ventriculocisternal administration of naloxone protects against severe hypotension during endotoxin shock, Brain Res. 194: 608–612.PubMedGoogle Scholar
  151. Jeffcoate, W. J., Herbert, M., Cullen, M. H., Hastings, A. G., and Walder, C. P., 1979, Prevention of effects of alcohol intoxication by naloxone, Lancet ii: 1157–1159.Google Scholar
  152. Jenck, F. P., Schmitt, P., and Karli, P., 1983, Morphine applied to the mesencephalic central gray suppresses brain stimulation induced escape, Pharmacol Biochem. Behav. 19: 301–308.PubMedGoogle Scholar
  153. Johannessen, J. N., Watkins, L. R., and Mayer, D. J., 1984, Nonserotonergic origins of the dorsolateral funiculus in the rat ventral medulla, J. Neurosci. 4: 757–766.PubMedGoogle Scholar
  154. Jungkinz, G., Nedopil, N., and Ruther, E., 1984, Acute effects of the synthetic analogue of methionine enkephalin FK 33–824 in schizophrenic patients. A double blind trial, Pharmacopsychiatry 17: 76–78.Google Scholar
  155. Kamerling, S. G., Martin, W. R., Wu, K. M., and Wettstein, J. C., 1983, Medullary kappa hyperalgesia mechanisms II. The effects of ethylketazocine administered into the fourth cerebral ventrical of the conscious dog, Life Sci. 33: 1839–1843.PubMedGoogle Scholar
  156. Kameyama, T., and Ukai, M., 1983, Multi-dimensional analyses of behavior in mice treated with morphine, endorphins and (des-tyrosinel)-gamma-endorphin, Pharmacol Biochem. Behav. 19: 671–677.PubMedGoogle Scholar
  157. Kasson, B. G., and George, R., 1983a, Endocrine influences on the actions of morphine. I. Alteration of target gland hormones, J. Pharmacol Exp. Ther. 224: 273–281.PubMedGoogle Scholar
  158. Kasson , B. G., and George, R., 1983b, Endocrine influences on the actions of morphine. III. Responses to hypothalamic hormones, Neuroendocrinology 37: 416–420.PubMedGoogle Scholar
  159. Kavaliers, M., Hirst, M., and Teskey, G. C., 1983, A functional role for an opiate system in snail thermal behavior, Science 220: 99–101.PubMedGoogle Scholar
  160. Kavaliers, M., Hirst, M., and Teskey, G. C., 1984, Opioid-induced feeding in the slug, Limax maximus, Physiol. Behav. 33: 765–768.Google Scholar
  161. Kavaliers, M., Hirst, M., and Teskey, G. C., 1985, Nocturnal feeding in the mouse— opiate and pineal influence, Life Sci. 36: 973–980.PubMedGoogle Scholar
  162. Kelsey, J. N., Belluzzi, J. D., and Stein, L., 1984, Does naloxone suppress self-stimulation by decreasing reward or by increasing aversion? Brain Res. 307: 55–60.PubMedGoogle Scholar
  163. Khazan N., Young, G. A., El-Fakany, E. E., Hong, O., and Calligaro, D., 1984, Sigma receptors mediate the psychotomimetic effects of n-allylnormetazocine (SKF-10,047), but not its opioid agonistic-antagonistic properties, Neuropharmacology 23: 983–988.PubMedGoogle Scholar
  164. Kinscheck, I. G., Watkins, L. R., and Mayer, D. J., 1984, Fear is not critical to classically conditioned analgesia: The effects of periaqueductal gray lesions and administration of chlordiazepoxide, Brain Res. 298: 33–44.PubMedGoogle Scholar
  165. Kiser, R. S., Jackson, S., Smith, R., Rees, L. H., Lowry, P. J., and Besser, G. M., 1983, Endorphin-related peptides in rat cerebrospinal fluid, Brain Res. 288: 187–192.PubMedGoogle Scholar
  166. Kishioka, A., Iguchi, Y., Ozaki, M., and Yamamoto, H., 1983, Effect of electrical lesioning of nucleus reticularis gigantocellularis of rat medulla oblongata on morphine analgesia, Folia Pharmacol Jpn. 82: 475–484.Google Scholar
  167. Kline, N. S., Li, C. H., Lehmann, H. E., Lajtha, A., Laski, E., and Cooper, T., 1977, Beta- endorphin-induced changes in schizophrenic and depressed patients, Arch. Gen. Psychiatry 34: 1111–1115.PubMedGoogle Scholar
  168. Koll, W., Haase, J., Block, G., and Muhlberg, B., 1963, The predilective action of small doses of morphine on nociceptive spinal reflexes of low spinal cats, Int. J. Neuropharmacol. 2: 57–65.Google Scholar
  169. Kordower, H. H., and Bodnar, R. J., 1984, Vasopressin analgesia: Specificity of action and non-opioid effects, Peptides 5: 747–756.PubMedGoogle Scholar
  170. Kovacs, G. L., Vescernyes, M., Laczi, F., Faludi, M., Telegdy, G., and Laszlo, F. A., 1985, Acute morphine treatment and morphine tolerance/dependence alter immunoreactive oxytocin levels in the mouse hippocampus, Brain Res. 328: 158–160.PubMedGoogle Scholar
  171. Kruger, L., and Liebeskind, J. C., 1984, Advances in Pain Research and Therapy: Neural Mechanisms of Pain, Raven Press, New York.Google Scholar
  172. Kumazawa, T., Eguchi, K., and Tadaki, E., 1985, Naloxone-reversible respiratory inhibition induced by muscular thin-fiber afferents in decerebrated cats, Neurosci Lett. 53: 81–86.PubMedGoogle Scholar
  173. LaGamma, E. F., Adler, J. E., and Black, I. B., 1984, Impulse activity differentially regulates [Leu]enkephalin and catecholamine characters in the adrenal medulla, Science 224: 1102–1104.PubMedGoogle Scholar
  174. Lai, Y., and Chan, S. H. H., 1982, Antagonization of clonidine- and morphine-promoted antinociception by kainic acid lesion of nucleus reticularis gigantocellularis in the rat, Exp. Neurol. 78: 38–45.PubMedGoogle Scholar
  175. Lal, H., Miksic, S., and Smith, N., 1976, Naloxone antagonism of conditioned hyperthermia: An evidence for release of endogenous opioid, Life Sci. 18: 971–976.PubMedGoogle Scholar
  176. Largent, B. L., Gundlach, L., and Snyder, S. H., 1984, Psychotomimetic opiate receptors labeled and visualized with (+)-[3H]3-(3-hydroxyphenyl)-N-(l-propyl)piperidine, Proc. Natl. Acad. Sci. USA 81: 4983–4987.PubMedGoogle Scholar
  177. Laubie, M., Schmitt, H., Vincent, M., and Remond, G., 1977, Central cardiovascular effects of morphinominetic peptides in dogs, Eur. J. Pharmacol. 46: 67–71.PubMedGoogle Scholar
  178. Laubie, M., Schmitt, H., and Vincent, M., 1979, Vagal bradycardia produced by microinjections of morphine-like drugs into the nucleus ambiguus in anesthetized dogs, Eur. J. Pharmacol. 59: 287–291.PubMedGoogle Scholar
  179. Leander, J. D., 1984, Kappa-opioid agonists and antagonists—effects on drinking and urinary output, Appetite 5: 7–14.PubMedGoogle Scholar
  180. Leander, J. D., 1985, Behavioral effects of agonist and antagonist actions at kappa-opioid receptors, in: Behavioral Pharmacology: The Current Status: Neurology and Neurobiology (L. S. Seiden and R. L. Balster, eds.), Liss, New York, pp. 93–110.Google Scholar
  181. Levine, A. S., and Morley, J. E., 1983, Adrenal modulation of opiate induced feeding, Pharmacol. Biochem. Behav. 19: 403–406.PubMedGoogle Scholar
  182. Lewis, J. W., Cannon, J. T., and Liebeskind, J. K., 1980, Opioid and nonopioid mechanisms of stress analgesia, Science 208: 623–625.PubMedGoogle Scholar
  183. Lewis, J. W., Tordoff, M. G., Sherman, J. E., and Liebeskind, J. C., 1982, Adrenal medullary enkephalin-like peptides may mediate opioid stress analgesia, Science 217:557–559.PubMedGoogle Scholar
  184. Lim, R. K. S., 1966, A revised concept of the mechanism of analgesia and pain, in: Pain (R. S. Knighton and P. R. Dumke, eds.), Little, Brown, Boston, pp. 117–154.Google Scholar
  185. Lotti, V. J., Lomax, P., and George, R., 1965, Temperature responses in the rat following intracerebral microinjection of morphine, J. Pharmacol. Exp. Ther. 150: 135–139.PubMedGoogle Scholar
  186. Lyness, W. H., Friedle, N. M., and Moore, K. E., 1979, Destruction of dopaminergic nerve terminals in nucleus accumbens: Effect on d-amphetamine self-administration, Pharmacol. Biochem. Behav. 11: 553–556.PubMedGoogle Scholar
  187. Macht, D. I., 1915, The history of opium and some of its preparations and alkaloids, JAMA 64: 477–481.Google Scholar
  188. Maier, S. F., Drugan, R. C., and Grau, J. W., 1982, Controllability, coping behavior, and stress-induced analgesia in the rat, Pain 12: 47–56.PubMedGoogle Scholar
  189. Mannisto, P. T., Rauhala, P., Tuominen, R., and Mattila, J., 1984, Dual action of morphine on cold-stimulated thyrotropin secretion in male rats, Life Sci. 35: 1101–1108.PubMedGoogle Scholar
  190. Mansour, A., and Valenstein, E. S., 1984, Morphine responsiveness and seizure proneness, Exp. Neurol. 85: 346–357.PubMedGoogle Scholar
  191. Margules, D. L., Lewis, M. J., Shibuya, H., and Pert, C. B., 1978, Beta-endorphin is associated with overeating in genetically obese mice (ob/ob) and rats (fa/fa), Science 202: 988–991.PubMedGoogle Scholar
  192. Margules, D. L., Boldman, B., and Finck, A., 1979, Hibernation: An opioid-dependent state? Brain Res. Bull. 4: 721–724.PubMedGoogle Scholar
  193. Martin, W. R., 1983, Pharmacology of opioids. 4, Pharmacol. Rev. 35: 283–323.PubMedGoogle Scholar
  194. Martinez, J. L., Jr., 1985, Central versus peripheral actions of Leu-enkephalin on acquisition of a one-way active avoidance response in rats, Brain Res. 327: 37–44.PubMedGoogle Scholar
  195. Matthews, R. T., and German, D. C., 1982, Electrophysiological evidence for morphine excitation of ventral tegmental area dopamine neurons, Soc. Neurosci. Abstr. 8: 777.Google Scholar
  196. Mayer, D. J., and Hayes, R., 1975, Stimulation-produced analgesia: Development of tolerance and cross tolerance to morphine, Science 188: 941–943.PubMedGoogle Scholar
  197. Mayer, D. J., and Price, D. D., 1976, Central nervous system mechanisms of analgesia, Pain 2: 379–404.PubMedGoogle Scholar
  198. Mayer, D. J., and Price, D. D., 1982, A physiological and psychological analysis of pain: A potential model of motivation, in: The Physiological Mechanisms of Motivation (D. W. Pfaff, ed.), Springer-Verlag, New York, pp. 433–471.Google Scholar
  199. Mayer, D. J., and Watkins, L. R., 1984, Multiple endogenous opiate and nonopiate analgesia systems, in: Advances in Pain Research and Therapy (L. Kruger and J. C. Liebeskind, eds.), Raven Press, New York, pp. 253–276.Google Scholar
  200. Mayer, D. J., Wolfle, T. L., Akil, H., Carder, B., and Liebeskind, J. C., 1971, Analgesia from electrical stimulation in the brainstem of the rat, Science 174: 1351–1354.PubMedGoogle Scholar
  201. Mayer, D. J., Price, D. D., and Becker, D. P., 1975, Neurophysiological characterization of the anterolateral spinal cord neurons contributing to pain perception in man, Pain 1: 51–58.PubMedGoogle Scholar
  202. McGinty, J. F., and Bloom, F. E., 1983, Double immunostaining reveals distinctions among opioid peptidergic neurons in the medial basal hypothalamus, Brain Res. 278: 145–154.PubMedGoogle Scholar
  203. McKay, L. D., Kenney, N. J., Edens, N. K, Williams, R. H., and Woods, S., 1981, Intra-cerebroventricular beta-endorphin increases food intake of rats, Life Sci. 29: 1429–1435.PubMedGoogle Scholar
  204. McLaughlin, C. L., and Baile, C. A., 1984a, Feeding behavior responses of Zucker rats to naloxone, Physiol. Behav. 32: 755–762.PubMedGoogle Scholar
  205. McLaughlin, C. L., and Baile, C. A., 1984b, Increased sensitivity of Zucker obese rats to naloxone is present at weaning, Physiol. Behav. 32: 929–934.PubMedGoogle Scholar
  206. McNicholas, L. F., and Martin, W. R., 1984, New and experimental therapeutic roles for naloxone and related opioid antagonists, Drugs 27: 81–93.PubMedGoogle Scholar
  207. Meisenberg, G., and Simmons, W. H., 1983, Centrally mediated effects of neurohypophyseal hormones, Neurosci. Biobehav. Rev. 7: 263–280.Google Scholar
  208. Melzack, R., 1973, The Puzzle of Pain, Basic Books, New York.Google Scholar
  209. Melzack, R., and Casey, K. L., 1968, Sensory, motivational and central control determinants of pain: A new conceptual model, in: The Skin Senses (D. Kenshalo, ed.) Charles C Thomas, Springfield, IL, pp. 423–439.Google Scholar
  210. Melzack, R., and Wall, P. D., 1965, Pain mechanisms: A new theory, Science 150: 971–979.PubMedGoogle Scholar
  211. Mendelson, S. D., and Gorzalka, B. B., 1984, Cholecystokinin-octapeptide produces inhibition of lordosis in the female rat, Pharmacol. Biochem. Behav. 21: 755–760.PubMedGoogle Scholar
  212. Meyerson, B. J., and Terenius, L., 1977, Beta-endorphin and male sexual behavior, Eur. J. Pharmacol. 42: 191.PubMedGoogle Scholar
  213. Mickley, G. A., and Stevens, K. E., 1983, Endogenous opiates mediate radiogenic behavioral change, Science 220: 1185–1187.PubMedGoogle Scholar
  214. Milke, D. H., and Gallant, D. M., 1977, Oral opiate antagonist in chronic schizophrenic—pilot study, Am. J. Psychiatry. 134: 1430.Google Scholar
  215. Millan, M. J., Przewlocki, R., Jerlicz, M., Gramsch, C., Hollt, V., and Herz, A., 1981, Stress-induced release of brain and pituitary beta-endorphin: Major role of endorphins in generation of hyperthermia, not analgesia, Brain Res. 208: 325–338.PubMedGoogle Scholar
  216. Millan, M. H., Millan, M. J., and Herz, A., 1984, The hypothalamic paraventricular nucleus: Relationship to brain and pituitary pools of vasopressin and oxytocin as compared to dynorphin, beta-endorphin and related opioid peptides in the rat, Neuroendocrinology 38: 108–116.PubMedGoogle Scholar
  217. Miller, G. C., Murgo, A. J., and Plotnikoff, N. P., 1983, Enkephalins-enhancement of active t-cell rosettes from lymphoma patients, Clin. Immunol. Immunopathol. 26:446–451.PubMedGoogle Scholar
  218. Moore, J. E., 1983, Arginine vasopressin enhances retention of morphine tolerance, Pharmacol. Biochem. Behav. 19: 561–566.PubMedGoogle Scholar
  219. Morley, J. E., and Levine, A. S., 1980, Stress-induced eating is mediated through endogenous opiates, Science 209: 259–1261.Google Scholar
  220. Morley, J. E., Levine, A. S., Nizielski, S., Gosnell, B. A., Plotka, E., Billington, C. J., and Seal, U. S., 1984, Species diversity and opioid feeding systems, in: Central and Peripheral Endorphins: Basic and Clinical Aspects, Physiopathological Aspects (E. E. Muller and A. R. Genazzani, eds.) Raven Press, New York, pp. 279–284.Google Scholar
  221. Murfin, R., Bennett, G. J., and Mayer, D. J., 1976, The effects of dorsolateral spinal cord (DLF) lesions on analgesia from morphine microinjected into the periaqueductal gray matter (PAG) of the rat, Soc. Neurosci. Abstr. 2: 946.Google Scholar
  222. Murphy, E. A., Porter, J. H., and Heath, G. F., 1985, Suppression of schedule-induced drinking and food-reinforced bar pressing by tail-pinch is not reversed by naloxone, Behav. Neural. Biol. 43: 86–99.PubMedGoogle Scholar
  223. Musto, D. F., 1973, The American Disease, Yale University Press, New Haven, CT.Google Scholar
  224. Myers, W. D., Ng, K. T., and Singer, G., 1984, Effects of naloxone and buprenorphine on intravenous acetaldehyde self-injection in rats, Physiol. Behav. 33: 449–456.PubMedGoogle Scholar
  225. Naber, D., Pickar, D., Post, R. M., Vankammen, D. P., Waters, R. N., Ballenger, J. C., Goodwin, F. K., and Bunney, W. E., 1981, Endogenous opoid activity and beta-endorphin immunoreactivity in CSF of psychiatric patients and normal volunteers, Am. J. Psychiatry 138: 1457–1462.PubMedGoogle Scholar
  226. Naber, D., Nedopil, N., and Eben, E., 1984, No correlation between neuroleptic-induced increase of beta-endorphin serum level and therapeutic efficacy in schizophrenia, Br. J. Psychiatry 144: 651–653.PubMedGoogle Scholar
  227. Nathan, P. W., and Smith, M. C., 1979, Clinico-anatomical correlation in anterolateral cordotomy, in: Advances in Pain Research and Therapy (J. J. Bonica, J. C. Liebeskind, and N. G. Albe-Fessard, eds.), Raven Press, New York, pp. 921–926.Google Scholar
  228. Neal, H., and Keane, P. E., 1978, The effects of local micro injections of opiates and enkephalins into the forebrain on the electrocorticogram of the rat, Electroencephalogr. Clin. Neurophysiol. 45: 655–665.PubMedGoogle Scholar
  229. Nedopil, N., and Ruther, E., 1979, Effects of the synthetic analogue of methionin enkephalin FK 33 824 on psychotic symptoms, Pharmakopsychiat. Neuro-Psych. 12: 277–280.Google Scholar
  230. Nemeroff, C. B., Oosbahr, A. J., Manberg, P. J., Ervin, G. N., and Prange, A. J., 1979, Alterations in nociception and body temperature after intra-cisternal administration of neurotensin, beta-endorphin, other endogenous peptides and morphine, Proc. Natl. Acad. Sci. U.S.A. 76: 5368–5371.PubMedGoogle Scholar
  231. Noordenbos, W., 1959, Pain, Elsevier, North Holland, Amsterdam.Google Scholar
  232. Oiltgen, P. R., Walsh, J. W., Hamann, S. R., Randall, D. C., Spurrier, W. A., and Myers, R. D., 1982, Hibernation “trigger”: Opioid-like inhibitory action on brain function of the monkey, Pharmacol. Biochem. Behav. 17: 1271–1274.Google Scholar
  233. Oley, N., Cordova, C., Kelly, M. L., and Bronzino, J. D., 1982, Morphine administration to the region of the solitary tract nucleus produces analgesia in rats, Brain Res. 236: 511–515.PubMedGoogle Scholar
  234. Olson, R. D., Fernandez, R. C., Kastin, A. J., Olson, G. A., Delatte, S. W., von Almen, T. K, Erickson, D. G., and Hastings, D. C., 1981, Low doses of naloxone and MIF-1 peptides increase fluid consumption in rats, Pharmacol. Biochem. Behav. 15: 921–924.PubMedGoogle Scholar
  235. Ossipov, M. H., and Gebhart, G. F., 1984, Light pentobarbital anesthesia diminishes the antinociceptive potency of morphine administered intracranially but not intrathecally in the rat, Eur. J. Pharmacol. 97: 137–140.PubMedGoogle Scholar
  236. Ostrowski, N. L., Rowland, N., Foley, T. L., Nelson, J. L., and Reid, L. D., 1981, Morphine antagonists and consummatory behaviors, Pharmacol. Biochem. Behav. 14: 549–559.PubMedGoogle Scholar
  237. Owen, M. D., Gisolfi, C. V., Reynolds, D. G., and Gurll, N. J., 1984, Autonomic effects of central injections of d-Ala2-metenkephalinamide (DAME) in the conscious monkey, Peptides 5: 737–742.PubMedGoogle Scholar
  238. Pae, Y. S., Lai, H., and Horita, A., 1985, Hyperthermia in the rat from handling stress blocked by naltrexone injected into the preoptic-anterior hypothalamus, Pharmacol. Biochem. Behav. 22: 337–340.PubMedGoogle Scholar
  239. Pang, I. H., Bernardinni, G. L., and Clark, W. G., 1984, Hyperthermic response of the cat to intraventricular injection of the opioid delta-receptor agonist D-Ala2-D-Leu5- enkephalin, Brain Res. Bull. 13: 263–268.PubMedGoogle Scholar
  240. Pasternak, G. W., Gintzler, A. R., Houghten, R. A., Ling, G. S. F., Goodman, R. R., Spiegel, K., Nishimura, S., et al., 1983, Biochemical and pharmacological evidence for opioid receptor multiplicity in the central nervous system, Life Sci. 33:167–174.PubMedGoogle Scholar
  241. Paterson, A. T., and Vickers, C., 1984, Saline drinking and naloxone: Light cycle dependent effects on social behaviour in male mice, Pharmacol. Biochem. Behav. 21: 495–500.PubMedGoogle Scholar
  242. Pazos, A., and Florez, J., 1984, A comparative study in rats of the respiratory depression and analgesia induced by mu- and delta-opioid agonists, Eur. J. Pharmacol. 99: 15–22.PubMedGoogle Scholar
  243. Penicaud, L., and Thompson, D., 1984, Effects of systemic intracerebroventricular naloxone injection on basal and 2-deoxy-D-glucose-induced ingestive behavior, Life Sci. 35: 2297–2302.PubMedGoogle Scholar
  244. Pert, A., and Sivit, C., 1977, Neuroanatomical focus for morphine and enkephalin- induced hypermotility, Nature 265: 645–646.PubMedGoogle Scholar
  245. Pert, C. B., and Snyder, S. H., 1973, Opiate receptor: Demonstration in nervous tissue, Science 179: 1011–1013.PubMedGoogle Scholar
  246. Pert, A., and Yaksh, T., 1974, Sites of morphine induced analgesia in the primate brain: Relation to pain pathways, Brain Res. 80: 135–140.PubMedGoogle Scholar
  247. Pert, C. B., Snowman, A. M., and Snyder, S. H., 1974, Localization of opiate receptor binding in synaptic membranes of rat brain, Brain Res. 70: 184–188.PubMedGoogle Scholar
  248. Pert, C. B., Kuhar, M. J., and Snyder, S. H., 1975, Autoradiographic localization of the opiate receptor in rat brain, Life Sci. 16: 1849–1854.PubMedGoogle Scholar
  249. Pertovaara, A., Kemppainen, P., Johansson, G., and Karonen, S. L., 1982, Ischemic pain nonsegmentally produces a predominant reduction of pain and thermal sensitivity in man: A selective role for endogenous opioids, Brain Res. 251: 83–92.PubMedGoogle Scholar
  250. Pfeiffer, A., Feuerstein, G., Kopin, I. J., and Faden, A. I., 1983, Cardiovascular and respiratory effects of mu-opiate and kappa-opiate agonists microinjected into the anterior hypothalmic brain area of awake rats, J. Pharmacol. Exp. Ther. 225: 735–741.PubMedGoogle Scholar
  251. Phillips, A. G., and Broekkamp, C. L. E., 1980, Inhibition of intravenous cocaine self- administration by rats after microinjection of spiroperidol into the nucleus accumbens, Soc. Neurosci. Abstr. 6: 105.Google Scholar
  252. Phillips, A. G., and Lepiane, F. G., 1980, Reinforcing effects of morphine microinjection into the ventral tegmental area, Pharmacol. Biochem. Behav. 12: 965–968.PubMedGoogle Scholar
  253. Plotnikoff, N. P., and Miller, G. C., 1983, Enkephalins as immunomodulators, Int. J. Immunopharmacol. 5: 437–442.PubMedGoogle Scholar
  254. Pollerberg, G. E., Costa, T., Shearman, G. T., Herz, A., and Reid, L. D., 1983, Opioid antinociception and positive reinforcement are mediated by different types of opioid receptors, Life Sci. 33: 1549–1560.PubMedGoogle Scholar
  255. Porreca, F., Filla, A., and Burks, T. F., 1983, Studies in vivo with dynorphin-(l-9): Analgesia but not gastrointestinal effects following intrathecal administration to mice, Eur. J. Pharmacol. 91: 291–294.PubMedGoogle Scholar
  256. Porreca, F., Mosberg, H. I., Hurst, R., Hruby, V. J., and Burks, T. F., 1984, Roles of mureceptors, delta-receptors and kappa-opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse, J. Pharmacol. Exp. Ther. 230: 341–348.PubMedGoogle Scholar
  257. Pottoff, P., Valentino, D., and Lal, H., 1979, Attenuation of morphine analgesia by lesions of the preoptic forebrain region in the rat, Life Sci. 24: 421–424.PubMedGoogle Scholar
  258. Price, D. D., and Dubner, R., 1977, Neurons that subserve the sensory-discriminative aspects of pain, Pain 3: 307–338.PubMedGoogle Scholar
  259. Price, D. D., and Mayer, D. J., 1975, Neurophysiological characterization of the anterolateral quadrant neurons subserving pain in M. mulatta, Pain 1: 59–72.Google Scholar
  260. Price, D. D., Hu, J. W., Dubner, R., and Gracely, R., 1977, Peripheral suppression of first pain and central summation of second pain evoked by noxious heat pulses, Pain 3: 57–68.PubMedGoogle Scholar
  261. Price, D. D., Hayes, R. L., Ruda, M., and Dubner, R., 1978, Spatial and temporal transformation of input to spinothalamic tract neurons and their relation to somatic sensation, J. Neurophysiol. 41: 933–947.PubMedGoogle Scholar
  262. Proudfit, H. K., and Anderson, E. G., 1975, Morphine analgesia: Blockade by raphe magnus lesions, Brain Res. 98: 612–618.PubMedGoogle Scholar
  263. Reynolds, D. V., 1969, Surgery in the rat during electrical analgesia induced by focal brain stimulation, Science 164: 444–445.PubMedGoogle Scholar
  264. Rigter, H., 1978, Attenuation of amnesia in rats by systemically administered enkephalins, Science 200: 83–85.PubMedGoogle Scholar
  265. Rigter, H., Greven, H., and Vanriezen, H., 1977, Failure of naloxone to prevent reduction of amnesia by enkephalins, Neuropharmacology 16: 545–547.PubMedGoogle Scholar
  266. Riley, A. L., Zellner, D. A., and Duncan, H. J.., 1980, The role of endorphins in animal learning and behavior, Neurosci. Biobehav. Rev. 4: 69–76.PubMedGoogle Scholar
  267. Rios, L. and Jacob, J., 1981, Comparisons des effects du chlorhydrate et de l’iodomethylate de naloxone sur le choc endotoxinique chez le rat anesthisie, Arch. Inst. Pasteur Tunis. 58: 313–327.PubMedGoogle Scholar
  268. Ritzmann, R. F., Lee, J. M., and Fields, J. Z., 1983, Effect of peptides on morphine- induced tolerance and physical dependence, Psychopharmacol. Bull. 19: 321–324.Google Scholar
  269. Roberts, D. C. S., Corcoran, M. E., and Fibiger, H. C., 1977, On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine, Pharmacol. Biochem. Behav. 6: 615–620.PubMedGoogle Scholar
  270. Roberts, D. C. S., Koob, G. F., Klonoff, P., and Fibiger, H. C., 1980, Extinction and recovery of cocaine self-administration following 6-hydroxy-dopamine lesions of the nucleus accumbens, Pharmacol. Biochem. Behav. 12: 781–787.PubMedGoogle Scholar
  271. Roby, A., Willer, J-C., and Bussel, B., 1983, Effect of a synthetic enkephalin analogue on spinal nociceptive messages in humans, Neuropharmacology 22: 1121–1136.PubMedGoogle Scholar
  272. Rodgers, R. J., 1977, Elevation of aversive threshold in rats by intra-amygdaloid injection of morphine sulphate, Pharmacol. Biochem. Behav. 6: 385–390.PubMedGoogle Scholar
  273. Rodgers, R. J., 1978, Influence of intra-amygdaloid opiate injections on shock thresholds, tail-flick latencies and open field behaviour in rats, Brain Res. 153: 211–216.PubMedGoogle Scholar
  274. Romangnano, M. A., and Hamill, R. W., 1984, Spinal sympathetic pathway: An enkephalin ladder, Science 225: 737–739.Google Scholar
  275. Rukebusch, Y., Bardon, T. H., and Pairet, M., 1984, Opioid control of the ruminant stomach motility: Functional importance of mu, kappa and delta receptors, Life Sci. 35: 1731–1738.Google Scholar
  276. Samanin, R., and Valzelli, L., 1971, Increase of morphine-induced analgesia by stimulation of the nucleus raphe dorsalis, Eur. J. Pharmacol. 16: 298–302.PubMedGoogle Scholar
  277. Samson, H. H., and Doyle, T. F., 1985, Oral ethanol self-administration in the rat: Effect of naloxone, Pharmacol. Biochem. Behav. 22: 91–100.PubMedGoogle Scholar
  278. Samson, W. K., McDonald, J. K., and Lumpkin, M. D., 1985, Naloxone-induced dissociation of oxytocin and prolactin releases, Neuroendocrinology 40: 68–71.PubMedGoogle Scholar
  279. Sanberg, D. E., and Segal, M., 1978, Pharmacological analysis of analgesia and self-stimulation elicited by electrical stimulation of catacholamine nuclei in the rat brain, Brain Res. 151: 529–542.Google Scholar
  280. Satoh, M., and Takagi, H., 1971, Effect of morphine on the pre- and postsynaptic inhibitions in the spinal cord, Eur. J. Pharmacol. 14: 150–154.Google Scholar
  281. Schoemaker, H., and Davis, T. P., 1984, Differential in vitro metabolism of beta-endorphin in schizophrenia, Peptides 5: 1049–1054.PubMedGoogle Scholar
  282. Schull, J., Kaplan, H., and O’brien, C. P., 1981, Naloxone can alter experimental pain and mood in humans, Physiol. Pharmacol. 9: 245–251.Google Scholar
  283. Schultzberg, M., Lundberg, J. M., Hokfelt, T., Terenius, L., Brandt, J., Elde, R. P., and Goldstein, M., 1978, Enkephalinlike immunoreactivity in gland cells and nerve terminals of the adrenal medulla, Neuroscience 3: 1169–1186.PubMedGoogle Scholar
  284. Schulz, R., Wilheim, A., and Dirlich, G., 1984, Intracerebral injection of different antibodies against endogenous opioids suggests alpha-neoendorphin participation in control of feeding behaviour, Naunyn Schmied Arch. Pharmacol. 326: 222–226.Google Scholar
  285. Shizgal, P., Bielajew, C., Corbett, D., Skelton, R., and Yeomans, J., 1980, Behavioral methods for inferring conduction velocity and anatomical linkage: I. Pathways connecting rewarding brain stimulation sites, J. Comp. Physiol. Psychol. 94: 227–237.PubMedGoogle Scholar
  286. Simone, D. A., Bodnar, R. J., Goldman, E. J., and Pasternak, G. W., 1985, Involvement of opioid receptor subtypes in rat feeding behavior, Life Sci. 36: 829–834.PubMedGoogle Scholar
  287. Sinclair, J. G., 1973, Morphine and meperidine on bulbospinal inhibition of the monosynaptic reflex, Eur. J. Pharmacol. 21: 111.PubMedGoogle Scholar
  288. Sivam, S. P., and Ho, I. K, 1984, Antinociceptive and gastrointestinal effects of opiates: an analysis of the nature of the involvement of mu and delta receptors of the central nervous system in morphine-tolerant and non-tolerant mice, Neuropharmacology 23: 105–108.PubMedGoogle Scholar
  289. Slizgi, G. R., Taylor, C. J., and Ludens, J. H., 1984, Effects of the highly selective kappa- opioid, U-50,488, on renal function in the anesthetized dog, J. Pharmacol. Exp. Ther. 230: 641–645.PubMedGoogle Scholar
  290. Smith, J. E., Co, C., and Lane, J. D., 1984, Limbic muscarinic cholinergic and benzodiazepine receptor changes with chronic intravenous morphine and self-administration, Pharmacol. Biochem. Behav. 20: 443–450.PubMedGoogle Scholar
  291. Sorensen, S. C., and Mattisson, K., 1978, Naloxone as an antagonist in severe alcohol intoxication, Lancet ii:688–689.Google Scholar
  292. Spiegel, K., Kourides, I. A., and Pasternak, G. W., 1982, Different receptors mediate morphine-induced prolactin and growth hormone release, Life Sci. 31: 2177–2180.PubMedGoogle Scholar
  293. Spiraki, C., Fibiger, H. C., and Phillips, A. G., 1982, Attenuation by haloperidol of place preference conditioning using food reinforcement, Psychopharmacology 77: 379–382.Google Scholar
  294. Stewart, J. J., and Curd, C. D., 1984, Antipropulsive effects of central and peripheral morphine in the rat gastrointestinal tract, J. Pharm. Pharmacol. 36: 476–477.PubMedGoogle Scholar
  295. Summy-Long, J. Y., Miller, D. S., Rosella-Dampman, L. M., Hartman, R. D., and Emmert, S. E., 1984, A functional role for opioid peptides in the differential secretion of vasopressin and oxytocin, Brain Res. 309: 362–366.PubMedGoogle Scholar
  296. Szechtman, H., Simantov, R., and Hershkowitz, M., 1981, Sexual behavior decreases pain sensitivity and stimulates endogenous opioids in male rats, Eur. J. Pharmacol. 70: 279–286.PubMedGoogle Scholar
  297. Takagi, H., 1980, The nucleus reticularis paragigantocellularis as a site of analgesic action of morphine and enkephalin, Trends Pharmacol. Sci. 1: 182–184.Google Scholar
  298. Takagi, H., Matsumura, M., Yanai, A., and Ogiu, K., 1955, The effect of analgesics on the spinal reflex activity of the cat, Jpn. J. Pharmacol. 4: 176–187.PubMedGoogle Scholar
  299. Takagi, H., Doi, T., and Akaike, A., 1976, Microinjection of morphine into the medial part of the bulbar reticular formation in rabbit and rat: Inhibitory effects on lamina V cells of spinal dorsal horn and behavioral analgesia, in: Opiates and Endogenous Opioid Peptides (H. W. Kosterlitz, ed.), North Holland, Amsterdam, pp. 191–198.Google Scholar
  300. Tang, F., Tang, J., Chou, J., and Costa, E., 1984, Age-related and diurnal changes in met5- enk-arg6-phe7 and met5-enkephalin contents of pituitary and rat brain structures, Life Sci. 35: 1005–1014.PubMedGoogle Scholar
  301. Tapia-Arancibia, L., and Astier, H., 1983, Opiate inhibition of K+-induced TRH release from superfused mediobasal hypothalami in rats, Neuroendocrinology 37: 166–168.PubMedGoogle Scholar
  302. Tepperman, F. S., Hirst, M., and Gowdey, C. W., 1981, Hypothalamic injection of morphine: Feeding and temperature responses, Life Sci. 28: 2459–2468.PubMedGoogle Scholar
  303. Terenius, L., 1973, Stereospecific interaction between narcotic analgesics and a synaptic plasma membrane fraction of rat cerebral cortex, Acta Pharmacol. Toxicol. 32: 317–320.Google Scholar
  304. Terenius, L., Washlstrom, A., and Agren, H., 1977, Naloxone (NarcanR) treatment in depression: Clinical observations and effects on CSF endorphins and monoamine metabolites, Psychopharmacology 54: 31–33.PubMedGoogle Scholar
  305. Terman, G. W., Shavit, Y., Lewis, J. W., Cannon, J. T., and Liebeskind, J. C., 1984, Intrinsic mechanisms of pain inhibition: activation by stress, Science 226: 1270–1277.PubMedGoogle Scholar
  306. Teschemacher, H. J., Schubert, P., and Herz, A., 1973, Autoradiographic studies concerning the supraspinal site of the antinociceptive action of morphine when inhibiting the hindleg flexor reflex in rabbits, Neuropharmacology. 12: 123–132.PubMedGoogle Scholar
  307. Teskey, G. C., Kavaliers, M., and Hirst, M., 1984, Social conflict activates opioid analgesic and ingestive behaviors in male mice, Life Sci. 35: 303–316.PubMedGoogle Scholar
  308. Thornhill, J. A., and Saunders, W., 1984, Ventromedial and lateral hypothalamic injections of naloxone or naltrexone suppress the acute food intake of food-deprived rats, Appetite 5: 25–30.PubMedGoogle Scholar
  309. Torebjork, H. E., 1974, Afferent C units responding to mechanical, thermal and chemical stimuli in human nonglabrous skin, Acta Physiol. Scand. 92: 374–390.PubMedGoogle Scholar
  310. Tsou, K., 1963, Antagonism of morphine analgesia by the intracerebral microinjection of nalorphine, Acta Physiol Sin. 26: 332–337.Google Scholar
  311. Tsou, K., and Jang, C. S., 1964, Studies on the site of analgesic action of morphine by intracerebral micro-injection, Scientia Sinica 13: 1099–1109.PubMedGoogle Scholar
  312. Turski, L., Havemann, IL, and Kuschinsky, K., 1983, The role of substantia nigra in motility of the rat. Muscular rigidity, body asymmetry and catalepsy after injection of morphine into the nigra, Neuropharmacology 22: 1039–1048.PubMedGoogle Scholar
  313. Ukponmwan, O. E., Rupreht, J., and Dzoljic, M. R., 1984, REM sleep deprivation decreases the antinociceptive property of enkephalinase-inhibition, morphine and cold-water swim, Gen. Pharmacol 15: 255–258.PubMedGoogle Scholar
  314. Urca, G., and Frenk, H., 1982, Systemic morphine blocks the seizures induced by intra- cerebroventricular (i. c. v.) injections of opiates and opioid peptides, Brain Res. 246: 121–126.PubMedGoogle Scholar
  315. Van Ree, J. M., 1977, Multiple brain sites involved in morphine antinociception, J. Pharm. Pharmacol 29: 765–766.PubMedGoogle Scholar
  316. Vanvugt, D. A., Bruni, J. F., and Meites, J., 1978, Naloxone inhibition of stress-induced increase in prolactin secretion, Life Sci. 22: 85–90.Google Scholar
  317. Vathy, I. U., Etgen, A. M., and Barfield, R. J., 1985, Effects of prenatal exposure to morphine on the development of sexual behavior in rats, Pharmacol Biochem. Behav. 22: 227–232.PubMedGoogle Scholar
  318. Veith, J. L., Sandman, C. A., Walker, J. M., Coy, D. H., and Kastin, A. J., 1978, Systemic administration of endorphins selectively alters open field behavior of rats, Physiol Behav. 20: 539–542.PubMedGoogle Scholar
  319. Verhoeven, W. M. A., Van Praag, H. M., and Van Ree, J. M., 1984, Repeated naloxone administration in schizophrenia, Psychiatr. Res. 12: 297–312.Google Scholar
  320. Vezina, P., and Stewart, J., 1985, Hyperthermia induced by morphine administration to the VTA of the rat brain: An effect dissociable from morphine-induced reward and hyperactivity, Life Sci. 36: 1095–1106.PubMedGoogle Scholar
  321. Vigouret, J., Teschemacher, H. J., Albus, K., and Herz, A., 1973, Differentiation between spinal and supraspinal sites of action of morphine when inhibiting the hindleg flexor reflex in rabbits, Neuropharmacology 12: 111–121.PubMedGoogle Scholar
  322. Vincent, S. R., Dalsgaard, C. J., Schultzberg, M., Holkfelt, T., Christensson, I., and Terenius, L., 1984, Dynorphin-immunoreactive neurons in the autonomic nervous system, Neuroscience 11: 973–988.PubMedGoogle Scholar
  323. Volavka, J., Mallya, A., Baig, S., and Perez-Cruet, J., 1977, Naloxone in chronic schizophrenia, Science 196: 1227–1228.PubMedGoogle Scholar
  324. Walker, L. A., and Murphy, J. C., 1984, Antinatriuretic effect of acute morphine administration in conscious rats, J. Pharmacol Exp. Ther. 229: 404–408.PubMedGoogle Scholar
  325. Wallace, M., Willis, G., and Singer, G., 1984, The effect of naloxone on schedule- induced and other drinking, Appetite 5: 39–44.PubMedGoogle Scholar
  326. Watkins, L. R., and Mayer, D. J., 1982a, Involvement of spinal opioid systems in foot- shock-induced analgesia: Antagonism by naloxone is possible only before induction of analgesia, Brain Res. 242: 309–316.Google Scholar
  327. Watkins, L. R., and Mayer, D. J., 1982b, Organization of endogenous opiate and non-opiate pain control systems, Science 216:1185–1192.Google Scholar
  328. Watkins, L. R., Griffin, G., Leichnetz, G. R., and Mayer, D. J., 1980, The somatotopic organization of the nucleus raphe magnus and surrounding brainstem structures as revealed by HRP slow-release gels, Brain Res. 181: 1–15.PubMedGoogle Scholar
  329. Watkins,ha L. R., Cobelli, D. A., Faris, P., Aceto, M. D., and Mayer, D. J., 1982a, Opiate vs non-opiate footshock-induced analgesia: The body region shocked is a critical factor, Brain Res. 242: 299–308.PubMedGoogle Scholar
  330. Watkins, L. R., Cobelli, D. A., and Mayer, D. J., 1982b, Classical conditioning of front paw and hind paw footshock-induced analgesia (FSIA): Naloxone reversibility and descending pathways, Brain Res. 243:119–132.Google Scholar
  331. Watkins, L. R., Cobelli, D. A., and Mayer, D. J., 1982c, Opiate vs non-opiate footshock- induced analgesia (FSIA): Descending and intraspinal components, Brain Res. 245: 97–106.Google Scholar
  332. Watkins, L. R., Cobelli, D. A., Newsome, H. H., and Mayer, D. J., 1982d, Footshock- induced analgesia is dependent neither on pituitary nor sympathetic activation, Brain Res. 245:81–96.Google Scholar
  333. Watkins, L. R., Kinscheck, I. B., and Mayer, D. J., 1983a, The neural basis of footshock analgesia: The effect of periaqueductal gray lesions and decerebration, Brain Res. 276:317–324.Google Scholar
  334. Watkins, L. R., Young, E. G., Kinscheck, I. B., and Mayer, D. J., 1983b, The neural basis of footshock analgesia: The role of specific ventral medullary nuclei, Brain Res. 276:305–315.Google Scholar
  335. Watkins, L. R., Drugan, R., Hyson, R. L., Moye, T. B., Ryan, S. M., Mayer, D. J., and Maier, S. F., 1984a, Opiate and non-opiate analgesia induced by inescapable tail- shock: Effects of dorsolateral funiculus lesions and decerebration, Brain Res. 291: 325325–336.PubMedGoogle Scholar
  336. Watkins, L. R., Faris, P. L., Komisurak, B. R., and Mayer, D. J., 1984b, Dorsolateral funiculus and intraspinal pathways mediate vaginal stimulation-induced suppression of nociceptive responding in rats, Brain Res. 294:59–65.Google Scholar
  337. Watkins, L. R., Frenk, H., Miller, J., and Mayer, D. J., 1984c, Cataleptic effects of opiates following intrathecal administration, Brain Res. 299: 43–49.PubMedGoogle Scholar
  338. Watkins, L. R., Frenk, H., Miller, J., and Mayer, D. J., 1984d, Effect of spinal cord lesions on convulsive activity induced by intrathecal morphine, Brain Res. 310: 337–340.PubMedGoogle Scholar
  339. Watkins, L. R., Johannessen, J. N., Kinscheck, I. B., and Mayer, D. J., 1984e, The neurochemical basis of footshock analgesia: The role of spinal cord serotonin and norepinephrine, Brain Res. 290: 107–117.PubMedGoogle Scholar
  340. Watkins, L. R., Katayama, Y., Kinscheck, I. B., Mayer, D. J., and Hayes, R. L., 1984f, Muscarinic cholinergic mediation of opiate and nonopiate environmentally induced analgesias, Brain Res. 300: 231–242.PubMedGoogle Scholar
  341. Watkins, L. R., Kinscheck, I. B., and Mayer, D. J., 1984g, Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide, Science 224: 395–396.PubMedGoogle Scholar
  342. Watkins, L. R., Kinscheck, I. B., Kaufman, E. F. S., Miller, J., Frenk, H., and Mayer, D. J., 1985a, Cholecystokinin antagonists selectively potentiate analgesia induced by endogenous opiates, Brain Res. 327: 181–190.PubMedGoogle Scholar
  343. Watkins, L. R., Kinscheck, I. B., and Mayer, D. J., 1985b, Potentiation of morphine analgesia by the cholecystokinin antagonist proglumide, Brain Res. 327: 169–180.PubMedGoogle Scholar
  344. Watson, S. J., Berger, P. A., Akil, H., and Barchas, J. D., 1978, Effects of naloxone on schizophrenia: Reduction in hallucinations in a subpopulation of subjects, Science 201: 73–76.PubMedGoogle Scholar
  345. Wauquier, A., Bovill, J. G., and Sebel, P. S., 1984, Electroencephalographic effects of fentanyl-, sufentanil-, and alfentanil anaesthesia in man, Neuropsychobiology. 11: 203–206.PubMedGoogle Scholar
  346. Webster, V. A. D., Griffiths, E. C., and Slater, P., 1983, Antinociceptive effects of thyrotrophin-releasing hormone and its analogues in the rat periaqueductal grey region, Neurosci. Lett. 42: 67–70.PubMedGoogle Scholar
  347. Wei, E. T., Tseng, L. F., Loh, H. H., and Li, C. H., 1977, Comparison of the behavioral effects of beta-endorphin and enkephalin analogs, Life Sci. 21: 321–328.PubMedGoogle Scholar
  348. Weiss, J., Thompson, M. L., and Shuster, L., 1984, Effects of naloxone and naltrexone on drug-induced hypothermia in mice, Neuropharmacology 23: 483–490.PubMedGoogle Scholar
  349. Whitnall, M. H., Gainer, H., Cox, B. M., and Molineaux, C. J., 1983, Dynorphin-A-(l- 8) is contained within vasopressin neurosecretory vesicles in rat pituitary, Science 222: 1137–1139.PubMedGoogle Scholar
  350. Wiesenfeld-Hallin, Z., and Sodersten, P., 1984, Spinal opiates affect sexual behaviour in rats, Nature 309: 257–258.PubMedGoogle Scholar
  351. Wikler, A., and Frank, K., 1948, Hindlimb reflexes of chronic spinal dogs during cycles of addiction to morphine and methadone, J. Pharmacol. Exp. Ther. 94: 382–400.PubMedGoogle Scholar
  352. Wilcox, R. E., and Levitt, R. A., 1979, Naloxone reversal of morphine catatonia: Role of caudate and periaqueductal gray, Pharmacol. Biochem. Behav. 9: 425–428.Google Scholar
  353. Willer, J. C., 1983, Nociceptive flexion reflexes as a tool for pain research in man, in: Motor Control Mechanisms in Health and Disease (J. E. Desmedt, ed.), Raven Press, New York, pp. 809–828.Google Scholar
  354. Willer, J. C., and Albe-Fessard, D., 1980, Electrophysiological evidence for a release of endogenous opiates in stress-induced analgesia in man, Brain Res. 198: 419–426.PubMedGoogle Scholar
  355. Willer, J. C., Dehen, H., and Cambier, J., 1981, Stress-induced analgesia in humans: Endogenous opioids and naloxone-reversible depression of pain reflexes, Science 212: 689–690.PubMedGoogle Scholar
  356. Willer, J. C., Roby, A., Boulu, P., and Albe-Fessard, D., 1982, Depressive effect of high frequency peripheral conditioning stimulation upon the nociceptive component of the human blink reflex. Lack of naloxone effect, Brain Res. 239: 322–326.PubMedGoogle Scholar
  357. Wilson, L., and Dorosz, L., 1984, Possible role of the opioid peptides in sleep, Med. Hypoth. 14: 269–280.Google Scholar
  358. Wise, R. A., 1984, Neural mechanisms of the reinforcing action of cocaine, in: NIDA Research Monograph Cocaine: Pharmacology, Effects, and Treatment of Abuse (J. Grabowski, ed.), NIDA, Rockville, MD, pp. 15–33.Google Scholar
  359. Wise, R. A., Spindler, J., Dewit, H., and Gerber, G. J., 1978, Neuroleptic-induced “anhedonia” in rats: Pimozide blocks the reward quality of food, Science 201: 262–264.PubMedGoogle Scholar
  360. Xenakis, S., and Sclafani, A., 1982, The dopaminergic mediation of a sweet reward in normal and VMH hyperphagic rats, Pharmacol. Biochem. Behav. 16: 293–302.PubMedGoogle Scholar
  361. Yaksh, T. L., 1978, Opiate receptors for behavioral analgesia resemble those related to the depression of spinal nociceptive neurons, Science 199: 1231–1233.PubMedGoogle Scholar
  362. Yaksh, T. L., and Rudy, T. A., 1976, Chronic catheterization of the spinal subarachnoid space, Physiol. Behav. 17: 1031–1036.PubMedGoogle Scholar
  363. Yaksh, T. L., and Rudy, T. A., 1977, Studies on the direct spinal action of narcotics in the production of analgesia in the rat, J. Pharmacol. Exp. Ther. 202: 411–428.PubMedGoogle Scholar
  364. Yaksh, T. L., and Wilson, P. R., 1979, Spinal serotonin terminal system mediates antinociception, J. Pharmacol. Exp. Ther. 208: 446–453.PubMedGoogle Scholar
  365. Yaksh, T. L., Yeung, J. C., and Rudy, T. A., 1976, Systematic examination in the rat of brain sites sensitive to the direct application of morphine: Observation of differential effects within the periaqueductal gray, Brain Res. 114: 83–104.PubMedGoogle Scholar
  366. Yeung, J. C., and Rudy, T. A., 1980a, Sites of antinociceptive action of systemically injected morphine—involvement of supraspinal loci as revealed by intracerebroventricular injection of naloxone, J. Pharmacol. Exp. Ther. 215: 626–632.PubMedGoogle Scholar
  367. Yeung, J. C., and Rudy, T. A., 1980b, Multiplicative interaction between narcotic agonisms expressed at spinal and supraspinal sites of antinociceptive action as revealed by concurrent intrathecal and intracerebroventricular injections of morphine, J. Pharmacol. Exp. Ther. 215:633–642.Google Scholar
  368. Yeung, J. C., Yaksh, T. L., and Rudy, T. A., 1975, Effects of brain lesions on the antinociceptive properties of morphine in rats, Clin. Exp. Pharm. Physiol. 2: 261–268.Google Scholar
  369. Yim, G. K. W., and Lowy, M. T., 1984, Opioids, feeding, and anorexias, Fed. Proc. 43: 2893–2896.PubMedGoogle Scholar
  370. Young, E. G., Watkins, L. R., and Mayer, D. J., 1984, Comparison of the effects of ventral medullary lesions on systemic and microinjection morphine analgesia, Brain Res., 290: 119–129.PubMedGoogle Scholar
  371. Young, G. A., 1980, Naloxone enhancement of punishment in the rat, Life Sci. 26:1787–1792.PubMedGoogle Scholar
  372. Zagon, I. S., and McLaughlin, P. J., 1983, Increased brain size and cellular content in infant rats treated with an opiate antagonist, Science 221: 1179–1180.PubMedGoogle Scholar
  373. Zagon, I. S., and McLaughlin, P. J., 1984, Naltrexone modulates body and brain development in rats: A role for endogenous opioid systems in growth, Life Sci. 35:2057–2064.Google Scholar
  374. Zagon, I. S., McLaughlin, P. J., and Zagon, E., 1984, Opiate, endorphins, and the developing organism: A comprehensive bibliography, 1982–1983, Neurosci. Biobehav. Rev. 8: 387–404.PubMedGoogle Scholar
  375. Zetler, G., and Morsdorf, K. H., 1984, Effects of ceruletide and cholecystokinin octapeptide on eating in mice. Interactions with naloxone and the enkephalin analogue, FK33- 824, Naunyn Schmied Arch. Pharmacol. 325: 209–213.Google Scholar
  376. Zorman, G., Belcher, G., Adams, J. E., and Fields, H. L., 1982, Lumbar intrathecal naloxone blocks analgesia produced by microstimulation of the ventromedial medulla in the rat, Brain Res. 236: 77–89.PubMedGoogle Scholar
  377. Zvartau, E. E., 1977, Action of naloxone on emotionally positive and antinociceptive effects of hypothalamic stimulation in rats, Bull. Exp. Biol. Med.-Engl. Tr. 88: 1306–1308.Google Scholar

Copyright information

© Plenum Press, New York 1987

Authors and Affiliations

  • David J. Mayer
    • 1
  1. 1.Department of Physiology and Biophysics, Medical College of VirginiaVirginia Commonwealth UniversityRichmondUSA

Personalised recommendations